BIIB Biogen Inc
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
$266.00 +4.78 (1.83%)
As of 03/23/2023 15:50:30 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Large cap
GICS sector: Health Care
Industry: Drug Manufacturers—General
Index country: USA
Country of incorporation: USA
IPO date: 02/08/2001
Outstanding shares: 144,485,646
Average volume: 979,224
Market cap: $39,047,245,832
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: 2455965
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%